September 17, 2015 10:41 AM | 30 seconds read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Analysts at Piper Jaffray downgraded
Mirati Therapeutics, Inc. (NASDAQ: MRTX) from Overweight to Neutral. The target price for Mirati Therapeutics has been lowered from $50 to $45. Mirati Therapeutics shares closed at $44.34 on Wednesday.Analysts at Macquarie downgraded
Starz (NASDAQ: STRZA) from undefined to Neutral. Starz shares closed at $40.44 on Wednesday.Analysts at UBS downgraded
Natural Resource Partners LP (NYSE: NRP) from Neutral to Sell. The target price for Natural Resources is set to $2.50. Natural Resources shares closed at $2.97 on Wednesday.BB&T Capital downgraded
Accuride Corporation (NYSE: ACW) to Hold. Accuride shares closed at $3.29 on Wednesday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.